Literature DB >> 10790204

Molecular basis of very long chain acyl-CoA dehydrogenase deficiency in three Israeli patients: identification of a complex mutant allele with P65L and K247Q mutations, the former being an exonic mutation causing exon 3 skipping.

H Watanabe1, K E Orii, T Fukao, X Q Song, T Aoyama, L IJlst, J Ruiter, R J Wanders, N Kondo.   

Abstract

Very long chain acyl-CoA dehydrogenase (VLCAD) deficiency is a life-threatening disorder of mitochondrial fatty acid beta-oxidation. We identified four novel mutations in three unrelated patients. All patients had the severe childhood form of VLCAD deficiency with early onset and high mortality. Immunoblot analysis revealed that VLCAD protein was undetectable in patients 2 and 3, whereas normal-size VLCAD protein and an aberrant form of VLCAD (4kDa smaller) were detected in patient 1. As expected, null mutations were found in patients 2 and 3: patient 2 is homozygous for a frameshift mutation, del 4 bp at 798-801, and patient 3 is homozygous for a nonsense mutation 65C>A(S22X). Patient 1 was homozygous for a complex mutant allele containing two alterations, including a 194C>T transition (P65L) and 739A>C transversion (K247Q); in the case of P65L, the amino acid change does not reduce enzyme activity. However, the nucleotide change resulted in exon 3 skipping, whereas the latter K247Q mutation had a drastic effect on enzyme activity. We verified these events by in vivo splicing experiments and transient expression analysis of mutant cDNAs. The P65L mutation locates 11 bases upstream of a splice donor site of intron 3. This is an example of an exonic mutation which affects exon-splicing. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10790204     DOI: 10.1002/(SICI)1098-1004(200005)15:5<430::AID-HUMU4>3.0.CO;2-1

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  6 in total

1.  Expression and characterization of mutations in human very long-chain acyl-CoA dehydrogenase using a prokaryotic system.

Authors:  Eric S Goetzman; Yudong Wang; Miao He; Al-Walid Mohsen; Brittani K Ninness; Jerry Vockley
Journal:  Mol Genet Metab       Date:  2007-03-19       Impact factor: 4.797

2.  Genetic risk for malignant hyperthermia in non-anesthesia-induced myopathies.

Authors:  Georgirene D Vladutiu; Paul J Isackson; Kenneth Kaufman; John B Harley; Beth Cobb; Lisa Christopher-Stine; Robert L Wortmann
Journal:  Mol Genet Metab       Date:  2011-07-12       Impact factor: 4.797

3.  Genetic basis for correction of very-long-chain acyl-coenzyme A dehydrogenase deficiency by bezafibrate in patient fibroblasts: toward a genotype-based therapy.

Authors:  S Gobin-Limballe; F Djouadi; F Aubey; S Olpin; B S Andresen; S Yamaguchi; H Mandel; T Fukao; J P N Ruiter; R J A Wanders; R McAndrew; J J Kim; J Bastin
Journal:  Am J Hum Genet       Date:  2007-10-29       Impact factor: 11.025

4.  Outcomes and genotype-phenotype correlations in 52 individuals with VLCAD deficiency diagnosed by NBS and enrolled in the IBEM-IS database.

Authors:  Loren D M Pena; Sandra C van Calcar; Joyanna Hansen; Mathew J Edick; Cate Walsh Vockley; Nancy Leslie; Cynthia Cameron; Al-Walid Mohsen; Susan A Berry; Georgianne L Arnold; Jerry Vockley
Journal:  Mol Genet Metab       Date:  2016-05-13       Impact factor: 4.797

5.  Clinical, Biochemical, and Molecular Features in 37 Saudi Patients with Very Long Chain Acyl CoA Dehydrogenase Deficiency.

Authors:  Abdulrahman Obaid; Marwan Nashabat; Majid Alfadhel; Ali Alasmari; Fuad Al Mutairi; Abdulrahman Alswaid; Eissa Faqeih; Aziza Mushiba; Marwah Albanyan; Maryam Alalwan; Deborah Marsden; Wafaa Eyaid
Journal:  JIMD Rep       Date:  2017-10-05

6.  Molecular and clinical characteristics of very-long-chain acyl-CoA dehydrogenase deficiency: A single-center experience in Saudi Arabia.

Authors:  Amal Alhashem; Sarar Mohamed; Manal Abdelraheem; Bushra AlGufaydi; Aida Al-Aqeel
Journal:  Saudi Med J       Date:  2020-06       Impact factor: 1.484

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.